Impact of COVID-19 on Neuro-Ophthalmology in the United States: A National Survey

Purpose: To evaluate the impacts of the COVID-19 on neuro-ophthalmology practice in the United States. Design: Cross-sectional study Methods: The North American Neuro-ophthalmology Society (NANOS) distributed a survey on the impact of COVID-19 on neuro-ophthalmic practice to its members. The survey consisted of 15 questions regarding the impact of the pandemic on neuro-ophthalmic practice and perspectives. Results: Twenty eight (28) neuro-ophthalmologists practicing in the United States responded to our survey. In this survey, 64% of survey respondents were male (n=18), while 36% were female (n=10). The average age of a respondent was 55 years old. According to 77% of survey respondents, various neuro-ophthalmic diseases were reported to have worsened during the pandemic including idiopathic intracranial hypertension, compressive optic neuropathy, optic neuritis, and giant cell arteritis. Conclusions: This survey represents one of the largest studies to describe the impact of the COVID-19 pandemic of neuro-ophthalmology. Given the underrepresentation of neuro ophthalmology in the United States as described in the literature, this study strengthens the need for more neuro-ophthalmologists to provide timely care, particularly during the pandemic. Further interventions to incentivize the pursuit of neuro-ophthalmology training may help combat the effects of COVID-19 on neuro-ophthalmic conditions.